Anti-Peptic Ulcer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Peptic Ulcer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type Proton Pump Inhibitors (PPIs) Potassium-Competitive Acid Blockers (P-CAB) Antacids H2 Antagonists Ulcer Protective Drugs Segment by Application Gastritis Gastric Ulcers Duodenal Ulcers Gastroesophageal Reflux Disease (GERD) By Company AstraZeneca Ask-pharm Takeda Yangtze River Pharm Shandong Luoxin Huadong Medicine Changzhou Siyao Beijing Yuekang Guangdong Dahua Xian Janssen By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia
1 Study Coverage 1.1 Anti-Peptic Ulcer Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Anti-Peptic Ulcer Drugs Market Size Growth Rate by Type 1.4.2 Proton Pump Inhibitors (PPIs) 1.4.3 Potassium-Competitive Acid Blockers (P-CAB) 1.2.4 Antacids 1.2.5 H2 Antagonists 1.2.6 Ulcer Protective Drugs 1.3 Market by Application
